Insights archive | Sagentia Innovation

Insights archive

Commercialising industrial products: navigating the valley of death

Taking a new industrial product from the proof-of-concept phase into technology validation and demonstration changes...
Industrial 14 January, 2022

Mixed Reality and healthcare: a new frontier

Mixed reality (MR) is currently the darling of immersive technology. It combines all the benefits of augmented reality...
Medical 06 January, 2022

Commercialising industrial products: look beyond technology readiness

The stakes are always high when a new industrial product reaches the commercialisation stage. But considering the wider...
Industrial 22 December, 2021

Podcast: Technology commercialisation: developing the optimum development cycle and process

Technology is at the very centre of our lives and has an impact on everything we do from how we spend our free time to...
Industrial 14 December, 2021

Three food and beverage trends to watch out for in 2022

Looking ahead, we see a number of global headwinds facing food and beverage companies, but with challenges come...
Food & Beverage 14 December, 2021

Season’s Greetings from the Sagentia Innovation team

  [video width="1920" height="1080...
Technologies 09 December, 2021

Data Strategies for Connected Health

The race is on to develop healthcare solutions which harness the enormous capabilities of sensor and communication...

Six steps to obtaining 510(k) premarket clearance for medical devices

Companies that think about regulatory strategy in the early stages of medical device development can benefit from...
Medical 26 November, 2021

Webinar: How to design your medical product to solve the user’s hidden needs

A talk on Human Centred Design. All medical device developers strive for better patient outcomes, but what makes a...
Medical 26 November, 2021

Webinar: The future of breast cancer screening: a patient-centric approach to invention

Breast cancer is the world’s most prevalent cancer. While breast cancer screening programs have significantly reduced...
Get in touch